Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss PTGX - Protagonist Therapeutics, Inc.
-105 K
LAST VALUE
40.74%
2 YEAR CAGR
14.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR